RELATING TO PRESCRIPTION DRUGS.
Summary
Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 20, 2021
Last action Dec 10, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
1
Jan 27, 2021
Committee
Referred to HHH, CPC, FIN, referral sheet 1
lower
Jan 21, 2021
Introduced
Introduced and Pass First Reading.
lower
Jan 20, 2021
Introduced
Pending introduction.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
RM
Roy M. Takumi
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 17
Scope: HI
Hi! I can help you understand HB 17. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline